This study highlights HMGB1 as a key regulator of esophageal cancer radioresistance, acting via the PI3K/AKT/ATM axis, and suggests that its inhibition could improve radiotherapy outcomes through enhanced cell death and impaired invasion. The gene discussed is PIK3CB; the disease is esophageal cancer.